Day: January 11, 2022

NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital (“Madison”) today announced the final close of Madison Realty Capital Debt Fund V LP (“Fund V”), raising $2.08 billion in equity commitments, exceeding the fund’s $1.75 billion target.

Fund V received significant support from existing investors as approximately 70% of the institutional LPs in Madison’s prior fund re-upped into Fund V.  Additionally, 52% of the capital committed for Fund V came from new limited partners, both domestically and abroad.

Madison’s global, institutional investor base has historically included public and corporate pension plans, sovereign wealth funds, endowments and foundations, insurance companies, family offices and high net worth individuals located in the United States, the Middle East, Europe, and Asia. Madison has now expanded its investor presence to include Australia, Latin America and Canada, as well as new regions within the Middle East, Europe and Asia.

Fund V expands on Madison’s investment strategy to serve as a single source of customized flexible financing solutions for borrowers’ unique needs providing them with speed and certainty of execution.  Fund V originates and acquires loans across asset classes including multifamily, mixed use, retail, office, industrial, land and hotel. Madison invests in transitional and special situation loans as well as provides financing for ground-up development and construction.

In 2021, Madison completed 72 transactions with a gross transaction volume of approximately $6.4 billion across all of its debt investment strategies.

Adam Tantleff, Managing Principal of Madison Realty Capital, said, “Our extensive experience through multiple cycles over the past 17 years is what led both existing and new investors to place their confidence in Madison during this unprecedented time.  We are grateful for the trust they have placed in our team, and look forward to continue executing on our investors’ behalf.”

Madison Realty Capital Debt Fund IV LP held its final close in 2019 and raised $1.14 billion in equity commitments. Since inception, Madison has completed approximately $20 billion in debt and equity transactions.

About Madison Realty Capital 

Madison Realty Capital is a vertically integrated real estate private equity firm that, as of December 31, 2021, manages approximately $8 billion in total assets on behalf of a global institutional investor base. Since 2004, Madison Realty Capital has completed approximately $20 billion in transactions providing reputable borrowers with flexible and highly customized financing solutions, strong underwriting capabilities, and certainty of execution. Headquartered in New York City, with an office in Los Angeles, the firm has approximately 70 employees across all real estate investment, development, and property management disciplines. Madison Realty Capital has been frequently named to the Commercial Observer’s prestigious “Power 100” list of New York City real estate players and is consistently cited as a top construction lender, among other industry recognitions. To learn more, follow us on LinkedIn and visit www.madisonrealtycapital.com.

Nathaniel Garnick/Grace Cartwright
Gasthalter & Co.
+1 (212) 257-4170
madisonrealty@gasthalter.com

EERA DeepWind Conference 2022

EERA DeepWind Conference 2022

TRONDHEIM, Norway, Jan. 11, 2022 (GLOBE NEWSWIRE) — Offshore wind power will be a key solution for Europe to reach its climate targets, and EERA, SINTEF and NTNU are showcasing the best and latest research and innovation in the field at the EERA DeepWind conference.

Skyrocketing energy prices in Europe and the pressing need to expand renewable energy to solve the climate crisis are making offshore wind more relevant than ever. “Offshore wind has the potential to meet our energy needs many times over,” says conference chair John Olav Tande, Chief Scientist SINTEF, “and we must work quickly to make use of its potential.”

The conference this year will be opened by Norwegian Minister of Petroleum and Energy Marte Mjøs Persen. Keynote speakers include – among many others – Manager of Offshore Wind Technology at Equinor, Hanne Wigum; professor at the North China Electric Power University’s Renewable Energy School, Yongqian Liu; and Senior Policy Officer at the European Commission, Matthijs Soede.

DeepWind features top experts and leaders in the fields of offshore wind policy, technology and research. Topics addressed this year are:

• New turbine and generator technology
• Grid connection and system integration
• Met-ocean conditions
• Operation and maintenance
• Installation and sub-structures
• Wind farm control
• Wind farm optimization
• Experimental testing and validation
• Sustainable development

For the second year in a row, the conference will be held online due to the ongoing pandemic. This provides a unique opportunity for people around the world who are interested in offshore wind power to participate and get up-to-date with the latest and best research and innovation in the field.

Anyone wishing to participate can register now to join us online 19-21 January!

The conference is organised by the European Energy Research Alliance (EERA), Norwegian research institute SINTEF, and Norwegian University of Science and Technology NTNU.

About SINTEF

SINTEF is one of Europe’s largest independent research organizations. SINTEF is a broad, multidisciplinary research organisation with international top-level expertise in the fields of technology, the natural sciences, medicine and the social sciences. We conduct contract R&D as a partner for the private and public sectors, and we are one of the largest contract research institutions in Europe. https://www.sintef.com/

For media accreditation, more information or interviews please contact:

Edwin Shankar, +47 415 23 012, edwin.shankar@leidar.com

Related Images

Image 1: EERA DeepWind Conference 2022

This content was issued through the press release distribution service at Newswire.com.

Attachment

• EERA DeepWind Conference 2022

Rancho Santa Margarita, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Following food authority EFSA’s ban of food additive titanium dioxide (TiO2), Blue California, the producer of natural science-based ingredients, launched novel food-grade whitening agents as a clean-label alternative to replacing potential health risk white colorant titanium dioxide.

“Brands that seek to replace the titanium dioxide white colorant will find many benefits to Blue California’s patent-pending food-grade whitening agents,” said Cuie Yan, Ph.D., vice president of encapsulation. “Our alternative to titanium dioxide is industry-changing with opacifying or whitening effects and excellent sensory benefits with a delicious creamy/rich mouthfeel, and contains proprietary ingredients that may have additional benefits such as supporting cognitive health.”

One of the most widely used food pigments is titanium dioxide (E171), an odorless powder that enhances foods’ white color or opacity. The most common titanium dioxide products are chewing gum, candies, pastries, chocolates, coffee creamers, and cake decorations. Titanium dioxide is also used as a pigment in paints and medicines.

In recent decades, concerns about the risks of titanium dioxide consumption have grown. The Food and Drug Administration (FDA) categorizes titanium dioxide as Generally Recognized as Safe (GRAS) at a maximum of 1% weight, but other organizations have issued warnings.

New governing rules in Europe are in action for producers to reformulate their products during a six-month window of phasing out titanium dioxide (E171). This follows the food authority European Food Safety Authority (EFSA) decision deeming titanium dioxide (E171) as “not safe” in 2021, and now a complete ban in 2022. France suspended the use of titanium dioxide in January 2020.

“Our clean-label, food-grade, and effective whitening agents are heat and pH stable for a variety of applications that match the performance of titanium dioxide yet overcome its safety concerns,” said Yan. “We’ve innovated these solutions as safe alternatives for brands that need to reformulate products rapidly due to government authorities concerns, bans, and phasing out titanium dioxide.”

Blue California’s patent-pending food-grade whitening powders have a similar size in diameter to the traditional titanium dioxide with higher L values (whiter), as shown in Table 1 below:

Table 1. Color and particle size comparison between Blue California’s novel food-grade whitening agents versus titanium dioxide whitening powder.

Note: The a and b ‘Color Measurement’ values are color depth markers of red, green, blue, and yellow. The ‘Redispersion Diameter’ measures the particle size.

The food-grade whitening agents have been tested in chewing gum compared to titanium dioxide. The whitening effect results of Blue California’s whitening agents are as remarkable as titanium dioxide. The whiteness increases as the dosage increases.

“We’re ready to collaborate with product developers to replace titanium dioxide with a clean-label, delicious, and safer whitening agents in their product lines,” said Yan.

About Blue California

Blue California is an entrepreneurial, science-based solutions provider and manufacturer of clean, natural, and sustainable ingredients used in food, beverage, flavor, fragrance, dietary supplements, personal care, and cosmetic products. For more than 25 years, Blue California has built a strong reputation for creating value in these diverse natural products and nature-inspired industries.

Attachment

• Chewing gum is whitened with titanium dioxide 

Ana Arakelian
Blue California
+1-949-635-1991
ana@bluecal-ingredients.com

Featured Image for Rangam

Featured Image for Rangam

SOMERSET, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) —  Rangam announces its continued growth of operations in EMEA and APAC regions with the appointment of Lee Corless as Senior VP of Sales & Partnerships. Lee will be leading the growth efforts that will allow Rangam to capitalize on the marketplace in both regions through its SourceAbled hiring solution.

Lee has years of experience working within the financial, technology, and recruitment industries. He is recognized as a world leader in the neurodiversity inclusion space and is an accomplished, in-demand, global speaker. Lee also assisted in designing a leading Autism at Work program within one of the largest international investment corporations.

I am honored and proud to join such a passionate company as we focus on SourceAbled in EMEA and APAC regions, collaborating with clients large and small, developing opportunities to strengthen their business, and giving real hope of a deserved future for many, many more candidates. Thank you to Nish and Hetal for bringing me into their family and trusting me with this responsibility.

—Lee Corless, Senior VP of Sales & Partnerships, Rangam

As an autistic self-advocate, Lee supports the advancement of adapting the workplace to embrace neurodiversity and encourage neurodivergent individuals to seek employment. Lee will promote SourceAbled in the EMEA and APAC regions and bring a heightened emphasis on diversity and inclusion. SourceAbled is Rangam’s autism, neurodivergence, and disability hiring solution that provides a collaborative, holistic solution implemented to develop people, establish inclusionary processes, and foster a culture of belonging.

“Rangam’s mission is to promote Employment for Everyone in workplaces beyond North America. Having a seasoned professional like Lee will greatly help us increase our footprint across EMEA and APAC regions. The current employment rate for individuals with autism in the United Kingdom is 21.7%, which is the lowest among people with disabilities. With the addition of Lee and his team, Rangam will continue to deliver its DE&I expertise to the EMEA and APAC talent markets that clearly need a better understanding of why autism can be an asset in the workplace. Our senior leadership team is looking forward to working with Lee to continue supporting our mission in EMEA and APAC,” said Nish Parikh, CEO and Co-founder of Rangam.

About Rangam
Rangam is a minority-, woman-, and disability-owned workforce solutions company with a mission to promote “Employment for Everyone,” including people with disabilities, autism, and neurodivergence, in addition to service veterans. The organization delivers innovative workforce solutions by designing an integrated and inclusive recruiting methodology. Rangam specializes in attracting and retaining talent globally for IT, Engineering, Scientific, Clinical, Healthcare, Administrative, Finance, and Business Professionals categories. To learn more, visit https://www.rangam.com/

Press Contact
Jerry Grider, Director of Marketing and Advertising
jerry@rangam.com
908-416-0834

Related Images

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Featured Image for Rangam

Commencement of regulatory pathway for U.S. market approval

Featured Image for GENinCode Plc

Featured Image for GENinCode Plc

OXFORD, England, Jan. 11, 2022 (GLOBE NEWSWIRE) — GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its Pre-Submission for Cardio inCode-SCORE with the Food and Drug Administration (FDA). Cardio inCode-SCORE is an in-vitro diagnostic test that assesses an individual’s combined genetic and clinical risk to predict and prevent cardiovascular disease (“CVD”).

Following extensive exchange of information and constructive discussions with the FDA, GENinCode has been invited by the FDA to file its Pre-Submission for Cardio inCode-SCORE. This marks the commencement of the regulatory pathway for U.S. market approval, which is anticipated later this year. The FDA views Pre-Submission as a structured process for managing and tracking interactions between manufacturers and the FDA about the application for approval or clearance, prior to final submission. It is an interactive process designed to give the opportunity to obtain FDA feedback on the application with the goal of making the end submission process more efficient.

Matthew Walls, CEO of GENinCode Plc, said: “Despite the delays driven by the pandemic, the filing of the Cardio inCode FDA Pre-Submission marks the start of the U.S. regulatory approval pathway and ongoing preparation for the launch of Cardio inCode-SCORE later this year. Recognition of inherited genetic contribution to the onset of cardiovascular disease continues to grow. We are well placed to improve the CVD standard of care by identifying individuals at high genetic risk who can be advised on lifestyle choices and access to personalised treatment to improve future health outcomes.”   

GENinCode specialises in polygenic risk assessment of CVD, the leading cause of death and disability worldwide. CVD is a broad disease classification that encompasses conditions such as coronary artery disease (causing angina, heart attack and heart failure), cerebrovascular disease (causing stroke, and some dementia), peripheral vascular disease (causing limb ischaemia, and some chronic kidney disease) and venous thromboembolism. CVD accounts for an estimated 17.9 million deaths globally each year and accounts for one in every four deaths in the United States. By 2030, the global cost of CVD is set to rise from approximately US$863 billion in 2010 to US$1,044 billion and is both a major health issue and global economic burden.

For more information, visit www.genincode.com.

Enquiries:

GENinCode Plc 
www.genincode.com
Matthew Walls, CEO
Paul Foulger, CFO

Wallbrook PR Limited
Tel +44 (0)20 7933 8780
Anna Dunphy / Paul McManus / Louise Ashe-Jepson
genincode@wallbrookpr.com

About GENinCode

GENinCode Plc is a UK-based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc. and in Europe through GENinCode S.L.U.

Related Images

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

• Featured Image for GENinCode Plc